Please login to the form below

Not currently logged in
Email:
Password:

antimicrobial

This page shows the latest antimicrobial news and features for those working in and with pharma, biotech and healthcare.

Bicycle Therapeutics to tackle AMR with government funding

Bicycle Therapeutics to tackle AMR with government funding

Biotech to discover new class of antibacterial agents. UK biotech company Bicycle Therapeutics is to develop a new class of antibacterial agents to tackle antimicrobial resistance (AMR) after receiving a grant ... Lee adds: “The Department of Health

Latest news

More from news
Approximately 39 fully matching, plus 62 partially matching documents found.

Latest Intelligence

  • Rules of engagement Rules of engagement

    Fewer than half of the nearly 10, 000 respondents had heard of the term ‘antimicrobial resistance’.

  • No incentive for a cure No incentive for a cure

    The stakes are too high for this not to happen. The risk we face from antimicrobial resistance and the current lack of new antibiotics tells us all we need to know

  • The threat of antimicrobial resistance The threat of antimicrobial resistance

    Why this issue is such a fundamental challenge. A look at some of the headline statistics on the antimicrobial resistance (AMR) issue is particularly sobering. ... market. About the AMR Centre. The AMR Centre is a key part of the UK’s response to the

  • Significant figures Significant figures

    us.”. An inhaled formulation of last-resort antibiotic Amikacin, ALIS taps into a need for new antibiotics as well as industry heads towards more joined-up thinking to tackle antimicrobial resistance.

  • Deal Watch March 2017 Deal Watch March 2017

    60. Cipla Agrimed. Ascendis Health. Acquisition. Veterinary antimicrobials and endectocides. 29.

More from intelligence
Approximately 5 fully matching, plus 7 partially matching documents found.

Latest appointments

More from appointments
Approximately 1 fully matching, plus 5 partially matching documents found.

Latest from PMHub

  • Multi Dose Drug Vial Adapters Market Segments, Opportunity, Growth and Forecast By End-use Industry 2018 - 2028

    Multi dose are specifically labelled by the manufacturers and contain an antimicrobial preservative to help prevent bacterial growth.

  • Navigating the antibiotic resistance crisis

    Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians navigating ... Antimicrobial resistance claims 5,

  • Antibiotic Resistance: Alarm bells ring louder than ever

    where antibiotics and the threat of antimicrobial resistance (AMR) became a hot topic in the mainstream media. ... Another angle is the development of small molecules that can be administered in conjunction with antimicrobials to prevent resistance

  • Cello Health

    Though international focus is turning to antimicrobial resistance and incentives are being provided for research into new drugs, there are many hurdles to be jumped before a blockbuster can be discovered

  • Blue Latitude Health

    Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians navigating

More from PMHub
Approximately 0 fully matching, plus 5 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Jet Off with Maloff Protect

Latest intelligence

International Childhood Cancer Day 2019
The number of new cases per year is shocking but the journey and the outlooks have vastly improved. We've pulled together an infographic to show just what we mean with...
Immuno-oncology in 2019: the rapid evolution continues
Immunotherapy is pharma’s biggest growth driver – how will it develop in 2019?...
Mixing up Focus Groups
A nice spread of homogeneous participants in a focus groups are often a go to for reliable research outcomes but there's much to be said for mixing it up and...

Infographics